Med-Tech Innovation February 12, 2024
PulmoBioMed – a Northumbria University spin-out which has developed a new lung test that could lead to earlier diagnosis of asthma and other conditions – has raised £1.4 million to help commercialise its technology.
The investment round was led by the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures, and included Northumbria University, SFC Capital and private investors in the USA, EU and UK. The company has also secured a £700,000 grant from Innovate UK to help it demonstrate the benefits of its technology.
PulmoBioMed’s breath sampling technology offers a non-invasive way to obtain fluid samples from the deep lung without contamination from fluids from the mouth. Most sampling devices cannot distinguish...
Today's Sponsors
Today's Sponsor